SÍNDROME ANTIFOSFOLIPIDO EN
PACIENTES CRÍTICOS

       
BIBLIOGRAFIA

  1. Bick R, Backer W: Thrombosis and Antiphospholipid Syndrome. Sem Thromb Hemost 1994; 20 (1): 55-62.
  2. Grahan CEH, Burton JL: Antiphospholipid Syndrome and Cutaneons Vasooclusive Disorders. Sem Dermat 1991; 10 (3): 152-159.
  3. Espinal ML, Rodríguez JM: Livedo Reticularis y Accidentes Cerebrovasculares. Actas Derm Sif 1993; 84 (11): 529-532.
  4. Hughes G: Simposio de Reumatología, junio 1996. Bs As. Argentina.
  5. Harris EN, Gharavi S, Patel P, et al: Evaluation of the Anticardiolipin Antibody Test. Report of an international workshopheld. Clin Exp Inmunol 1987; 68: 215-222.
  6. Asherson R: The Primary Antiphospholipid Syndrome. Major Clinical and Serologic Features. Medicine (Baltimore) 1989; 68: 366-374.
  7. Hughes G. Harris N, Gharavi A: The Anticardiolipin Syndrome. J Reum 1986; 13 (3): 486-489.
  8. Harris E, Baguley E: Clinical and Serological Features of the Antiphospholipid Syndrome. Br J Rheum 1987; 26: 1-9.
  9. Galli M, Finazzi G: Thrombocytopenia in Antiphospholipin Syndrome. Br J Hematol 1996; 93: 1-5.
  10. Muir K, Squire Y: Anticardiolipin Antibodies in an Unselected Stroke Population. Lancet 1994; 344: 452-6.
  11. Brey R, Gharavi M: Neurologic Complications of Antiphospholipid Antibodies. Rheum Dis Clin North Am 1993; 19 (4) : 833-851.
  12. Love P, Santoro S: Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erithematons and no SLE Disorders. Ann Int Med 1990; 112: 682-95.
  13. Sánchez Rodríguez JA, Oterino M, Fernández H, et al: Incidencia del Síndrome Antifosfolípido en las Manifestaciones Clínicas y Biológicas del LES. Rev Clin Esp. 1997; 197: 669-74.
  14. Alarcon Segovia D, Cabral A: Antiphospholipid Antibodies. Where do They Come from? Where do They Go?. J Rheum 1994; 21(6): 982-89.
  15. Asherson R, Doherty D: Mayor Histocompatibility Complex. Associations with Primary Antiphospholipid Syndrome. Arth Rheum 1992; 35: 124-125.
  16. Lockshin M: Answers to the Antiphospholipid Syndrome. N E J M 1995; 332: 1025-27.
  17. Lockshin M: Antiphospholipid Antibodies Syndrome. Rheum Dis Clin North Am 1994; 20: 45-9.
  18. Prieto J, Jusk J: Anticardiolipid Antibodies in Chronic Hepatits C. Implications of hepatitis C virus as the cause of Antiphospholipid Syndrome. Hepatology 1996; 23 (2): 199-204.
  19. Gharavi A, Sammaritano L: Characteristic of human Inmunodeficincy Virus and Chlorpromazine Induced Antiphospholipid Antibodies: effects of B2 Glycoprotein I on Binding to Phospholipid. J Rheum 1994; 21: 94-9.
  20. Alarcón Segovia D, Sanchez Guerrero J: Primary Antiphospholipid Syndrome. J Rheum 1989; 161:482-9.
  21. Hughes G: Thrombosis, Abortim, Cerebral Disease and the Lupus Anticorgulant. Br Med J 1983; 287: 1088-9.
  22. Firshman P: Prevention of Fetal Loss in Experimental Antiphospholipid Syndrome by In vivo administration of Recombinant Interleukin 3. J Clin Invest 1993; 91: 1834-37.
  23. Derkson R, Christians GC: Inmunology in medical practice. Antiphospholipid antibodies in pregnancy. Ned Tijdschr Geneeskd 1997(Abs); 141 (37): 1769-73.
  24. Rote NS, Vog ht: The Role of Placental Trophoblast in the Pathophysiology of the Antiphospholipid Antibodies Syndrome. Am J Reprod Inmunology 1998; 39(2): 125-6.
  25. Firshman P, Falach E: Aspirin Modulares Interleukin 3 production. Additional Explanation for the Preventive effects of Aspirin in Antiphospholipid Syndrome. J Rheum 1995; 22: 1086-90.
  26. Silver R, Praceman A: Understanding Prostaglandin Metabolities and Platelet Activating Factor, in the Pathophisiology and Treatment of the Antiphospholipid Syndrome. Clin Perinatol 1995; 22 (2): 357-73.
  27. Jacob G, Blank M: Differential effects of Anti B2 GPI Antibodies on Endothelial Cells and on the manifestations of Experimental Antiphospholipid Syndrome. Circulation 1998; 97: 900-906.
  28. Jacob G, Gilburd B: Target Recognition of B2 Glycoprotein I (B2 GPI) Dependent Anticardiolipin Antibodies: Evidence of Involvement of fourth Domain of B2 GPI in Antibody Binding. J Inmunol 1998; 160: 3917-23.
  29. Provenzale J, Ortel T, Aller N: Systemic Thrombosis in Patients with Antiphospholipid Antibodies. Lesion Distributions and Imaging Findings. Am J Roentgenol 1998; 170: 285-290.
  30. Godeaud B, Piette J Ch: Specific Antiplatelet Glycoprotein Autoantibodies are Associated with the Trombocytopenia of primary Antiphospholipid Syndrome. Br J Dermatol 1997; 98: 873-79.
  31. Marc M: Essential Trombocytemia: A cause of Sneddon’s Syndrome. Lancet 1996; 347: 395.
  32. Brey R, Gharavi M: Neurologic Complications of Antiphospholipid Syndrome. Rheum Dis Clin North Am 1993; 19 (4): 833-51.
  33. Matsushita T, Kauda T: Recurrent Accute Transverse Mielopathy. Rinsho Shinkeigaku 1997 (abs); 37 (11): 987-91.
  34. Nacredorp M, Spiera H: Sudden Sensoneural Hearing Loss in Patients with SLE or Lupus Like Syndrome And Antiphospholipid Antibodies. J Rheum 1998; 25 (3): 589-592.
  35. Nagai S, Horie Y: Superior Sagittal Sinus Thrombosis Associated with Primary Antiphospholipid. Neurol Med Clin Tokyo 1998 (abs); 38 (1): 34-9.
  36. Ruiz Arquelles GJ, Guzman Ramos J: Refractory hiccough Heralding Transverse Myelitis in the Primary Antiphospholipid Syndrome. Lupus 1998; 7(1):49-59.
  37. Sunden Culiberg J, Tedroff J: Reversible Chorea in Primary Antiphospholipid Syndrome. Mov Disord 1998 (abs); 13 (1): 147-49.
  38. Reino S, Muñoz Rodriguez F J: Optic Neuropathy in the Primary Antiphospholipid Syndrome. Report of a Case and Review of the Literature. Clin Rheum 1997; 16 (6): 629-631.
  39. Watanabe H, Hakusins: A Case of Antiphospholipid Syndrome Associated with Myasthenia Gravis. Rinsho Shinkeigaku 1997 (abs); 37 (7): 641-644.
  40. Brey R, Hart R: Antiphospholipid Antibodies in Acute non Hemorragic Stroke seen with in six hours after onset. Acta Neurol Scand 1995 (abs); 92: 69-71.
  41. Hughes G: The Antiphospholipid Syndrome: Ten years on. Lancet 1993; 342: 341-344.
  42. Kamashta M, Hughes G: Thrombosis in the Antiphospholipid Antibody Syndrome. N E J M 1995; 333: 665.
  43. Espinosa Rosales F, Bernon Perez R: Transversal Myelitis as an Initial Manisfestation of a Secundary Antiphospholipid Syndrome. Report of a Case. Allergol Inmunopathol 1995; 23 (5): 248-250.
  44. Lie J, Kabayashi: Systemic and Cerebral Vasculitis Coexisting with disseminated Coagulopathy in Systemic Lupus Eritemathous Associated with Antiphospholipid Syndrome. J Rheum 1995; 2: 2173-6.
  45. Briley DP, Boull B: Neurological Diseases Associated with Antiphospholipid Antibodies. Am Neurol 1989; 25: 221-7.
  46. Fields R, Sibbit W: Neuropsichiatric Lupus Eritematous Cerebral Infarctions and Cardiolipin Antibodies. Am Rheum Dis 1990; 49: 114-8.
  47. Orefice G, De Joanna G: Benign Intracranial Hipertention: A non Trombotic Complication of the Primary Antiphospholipid Syndrome? Lupus 1995; 4: 324-6.
  48. Castañon C, Amigo M: Ocular Vaso-oclusive Disease in Primary Antiphospholipid Syndrome. Ophtalmology 1995; 102: 256-262.
  49. Medina M, Ortega G: Adrenal Insufficiency Associated with Primary Antiphospholipid Syndrome. Ann Int Med 1995; 25 (2): 109-116.
  50. Taylor L: Antiphospholipid Antibodies in Vascular Surgery Patient. Am Surg 1994; 220: 544-551.
  51. Cervera R, Asherson R: Clinicopathologic Correlations of the Antiphospholipid Syndrome. Sem Arth Rheum 1995; 24 (4): 262-272.
  52. Eken J, Poe R: Antiphospholipid Antibody Syndrome Presenting as a Refractory non Inflamatory Pulmonar Vasculopathy. Chest 1997; 112: 1707-10.
  53. Argento A, Di Benedetto R: ARDS and Adrenal Insufficiency associated with the Antiphospholipid Antibody Syndrome. Chest 1998; 113: 1136-38.
  54. Mazzuchelli R, Barbadillo C: Catastrofhic Antiphospholipid Syndrome: A Rare manifestation of the Antiphospholipid Syndrome. Clin Exp Rheum 1993; 11: 653-657.
  55. Wiechens B, Shroeder J: Primary Antiphospholipid Antibody Syndrome and Retinal oclusive Vasculopathy. Am J Ophthalm 1997; 123 (6): 848 -50.
  56. Takeuchi S: Primary Antiphospholipid Syndrome with caute Myocardial Infarction recanalised by PTCA. Heart 1998; 79 (1): 96-98.
  57. Agirbash M A, Hanson D E: Resolution of Vegetation with anticoagulation after Myocardial Infarction in Primary Antiphospholipid Syndrome. J Am Soc Echocardiog 1997; 10 (8): 877-80.
  58. Castro Y, Otero C: Intracardiac Thrombosis in a Patient with Primary antiphospholipid Syndrome. Report of a Case. Rev Med Clin 1996; 124 (11): 1368-73.
  59. Lee HY, Park YW: Mesentering and Portal Venous Destruction Associated with Primary Antiphospholipid Syndrome. J Gastroenterol Hepatol 1997; 12 (12): 822-6.
  60. Kurz R, Elder A: Mesenteric Infarct in Primary antiphospholipid Antibody Syndrome. Gastroenterology 1997; 35 (9): 669-672.
  61. Amigo M, Garcia Torres R: Renal Involvement in Primary Antiphospholipid Syndrome. J Rheum.1992; 19: 1181-5.
  62. Kon S, Kwan J: Reversible Renal Failure due to the Antiphospholipid Syndrome, pre Eclampsia and Renal Trombotic Microangiopathy. Clin Nephrol 1995; 4 (4): 271-273.
  63. Kadhakrishman J, Williams C: Renal Transplantation in Anticardidipin Antibody Positive Lupus Eritematous Patients. Am J Kidney Dis 1994; 23: 286-9.
  64. Rojas Poceros: Recurrent Fetal Death and Antiphospholipid Antibody Syndrome. A Case Report. Ginecol Obstet Mex 1997; 65: 523-8.
  65. Martínez J, Comas C: Biochemical and Doppler Prediction of poor Perinatal outcome in a Fetus with four Umbilical Vessels. Eur J Obstet Gynecol Reprod Biol 1995 (abs); 62 (1): 145-7.
  66. Silver R, Branch W: Should we Treat Woman who have Antiphospholipid Syndrome? Contemp Obstet Gynecol 1994 (abs); 63-83.
  67. Robbins DL, Lung S: Effect of Anticardiolipin B2 Glycoprotein I Complexes on Production of Thromboxane A2 by Platelets from Patients with the Antiphospholipid Syndrome. J Rheum 1998; 25 (1): 51-6.
  68. Kazunobu O: A Case of Sneddon ‘s Syndrome with positive ANA and Anticardiolipin Antibodies: Primary Antiphospholipid Syndrome? J Dermatol 1990; 17: 489-92.
  69. Zelger B, Sepp N: Sneddon’s Syndrome. Arch Dermatol 1993; 129: 437-447.
  70. Piette J Ch: The Mistery of Antiphospholipid Antibodies in Sneddon’s Syndrome. Arch Dermatol 1994; 130 (70): 519-520.
  71. Francés C, Le Longueze M: Prevalence of Antiendothelial cell Antibodies in Patients with Sneddon’s Syndrome. J Am Acad Dermatol 1995; 33: 64-8.
  72. Dacud MS, Wilrnoth GJ: Sneddon’s Syndrome. Sem Dermatol 1995; 14 (2): 166-172.
  73. Lipsker D, Piette JCh: Annular Atrophic Lichen Planos and Sneddon’s Syndrome. Dermatol 1997; 195 (4): 402-3.
  74. Porta-Etessan J: Clinical Manifestations Associated with Antiphospholipid Antibodies. Ann Int Med 1997; 14 (12): 636-646.
  75. Lawrie AS, Puray G: Monitoring of oral Anticoagulant Therapy in Anticoagulant Positive Patients with the Antiphospholipid Syndrome. Br J Haematol 1997; 98: 887-892
  76. Khamashta MA, Cuadrado MJ: The Management of Thrombosis in the Antiphospholipid Antibody Syndrome. N E J M 1995; 332: 993-7.
  77. Porziov MG: Atypical Renal onset and Involvement in Primary Antiphospholipid Syndrome in a child. Clin Exp Rheum 1998; 16 (1): 102.
  78. Michel M, Bourquelot P: Essential Thrombocythaemia: A cause of Sneddon’s Syndrome. Lancet 1996; 347: 395.
  79. Rodríguez González D: Antiphospholipid Antibody Syndrome, Molar Pregnancy and Cerebral Infarct. A case Report. Ginecol Obstet Mex 1998; 66: 18-20.
  80. Gilkeson RC: Thoracic imaging features of Patients with Antiphosphopid Syndrome Antibodies. J Comput Assist Tomogr 1998; 22 (2): 241-4.
  81. Reyes Iglesias Y, Ortiz A: Coexistence of Primary Antiphospholipid Syndrom and proteins defficiency in a Hispanic Man with Ischemic Stroke. South Med J 1998; 91 (3): 296-8.
  82. Shah NM, Khamashta MA: Outcome of Patients with Anticardiolipin antibodies: a 10 year follow up of 52 patients. Lupus 1998; 7 (1): 3-6.
  83. Blank M, George J, Fishman P: Ciprofloxacin Inmunodulation of Experimental Antiphospholipid Syndrome Associated with elevation of Interleukin 3 and Granulocyte Macrophage Colony stimulating Factor Expression. Arth Rheum 1998; 41 (2): 224-2.
  84. Kuttch W T: Antiphospholipid Antibodies and Reproduction. J Reprod Inmunol 1997; 35 (2): 151-71.
  85. Inanc M, Radway Bright EL: Beta 2 Glycoprotein and Anti B2 Glycoprotein I Antibodies: Where are we now?. Br J Rheum 1997; 36 (12):1247-57.
  86. Lakasing l, Poston L: Adverse pregnancy outcome in the Antiphospholipid Syndrome: Focus for Future Research. Lupus 1997; 6 (9): 681-4.
  87. Nakajima T, Ando H: Succesful thromboendarterectomy for Chronic Pulmonary embolism in a Patient with and Antiphospholipid Syndrome. Jpn Circ J 1997 (abs); 6 (11): 958-64.
  88. Petri M: Antiphospholipid Antibody Syndrome an Acquires Cause of Venous and Arterial Hypercoagulability. M Sinai J Med 1997 (abs); 64(6): 376-82.
  89. Hoffman M, Burke M: Primary Biliary Cirrhosis Associated with Antiphospholipid Syndrome. Isr J Med Sci 1997 (abs); 33 (10): 681-6.
  90. Di Simone N, Ferrazzani S: Heparin and Low Dose Aspirin restore Placental Human Chorionic Gonadotrophin Secretion Abolished by Antiphospholipid Antibody containing Sera. Human Reprod 1997; 12 (9): 2061-5.
  91. Specker C, Rademacher J: Cerebral Microemboli in patient with Antiphospholipid Syndrome. Lupus 1997; 6 (8): 638-44.
  92. Eagle H, De Sanctis A: La práctica de la Cardiología. Normas del Massachusetts General Hospital. 2º edición.
  93. Sans Sabrafen J: Hematología clínica. 3º edición.
  94. Lilly CM: Pentoxifillyne prevents Tumor Necrosis Factor Induced Lung injury. Am Rev Resp Dis 1988; 139: 1361-68.
  95. Kavanaugh A: Danazol Therapy in Trombocitopenia Associated with Antiphospholipid Antibodies Syndrome. Ann Int Med 1994; 121: 767-8.
  96. Krause Y, Blank M: Abrogation of Experimental Sistem Lupus Erithematours and Primary Antiphospholipid Syndrome with Intravenous Gamma Globulin. J Reum 1995; 22: 1068-74.
  97. Blank M, Krouse Y: Bromocriptin Inmunomodulation of Experimental SLE and Primary Antiphospholipid Syndromes Via Induction of Nonspecific T supressors Cells. Cell Inmunol 1995; 162: 114-22.
  98. Asherson R: The Catastrophic Syndrome. J Rheumatol 1992; 19: 508-512.
  99. Narbay G: Sneddon’s Syndrome in a Patient with Homonymous Hemianopia with macular sparing. Bull Soc Belge Ophtalm 1996 (abs); 263: 103-7.
  100. .Devuyst G: Neuropathological finding of a Sneddon’s Syndrome Presenting with dementia nor Preceded by Clinical Cerevrovascular Events. Stroke 1996; 27 (5): 1008 -10.
  101. Rodríguez de la Serna: Síndrome de Anticuerpos Antifosfolípidos. Trat Med Int Medicine. Reumatol (III) 1993; 542 - 544.
  102. Gibson G, Gibson L: Skin Necrosis Secondary to Low molecular weight Heparin in a Patient with Antiphospholipid Antibody Syndrome. J Am Acad Dermatol 1997; 37 (5): 855-9.
  103. Roubey RA: Inmunology of the Antiphospholipid Andtibody Syndrome. Arth Rheum 1996; 39 (9): 1444-54.
  104. Praprotnik S: A decrease in Antiphospholipid Antibodies before a Thrombotic Event. Clin Rheum 1996; 15 (3): 298-300.
  105. Kandiah DA: Laboratory Detection of Antiphospholipid Antibodies. Lupus 1996; 5 (2): 160-2.
  106. Hojnik M, George J: Heart Value Involvement (Libman-Sacks endocarditis) in the Antiphospholipid Syndrome. Circulation 1996; 93 (8): 1579 - 87.
  107. Merkel P, Pierangeli S: The Prevalence and Clinical Associations of Anticardiolipin Antibodies in a Large Inception Cohort of Patients with connective Tissue Diseases. Am J Med 1996; 101: 576-83.
  108. .Lockshin MD: Anticuerpos Antifosfolípidos. JAMA (ed. Arg.) 1998; 7 (2): 85-88.
    109.

arrwder.gif (1268 bytes)